Metraipolis › archive › dc_2d61e97ec015

Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study… — Europe PMC PMID:42015349

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42015349
DOI
10.1080/15384047.2026.2662031
License (as archived)
solo-consultazione
Archived
2026-11-03T08:06:29.193Z
SHA-256 of the archived text
17daff6d03f1f7c73e03159b5961c57feafe1cc85b1adee916726d73e0666cf9
Stable URL of this page
https://metraipolis.com/documento/dc_2d61e97ec015

How to cite

Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study… — Europe PMC PMID:42015349 — Europe PMC (en), https://europepmc.org/article/MED/42015349 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2d61e97ec015 (Metraipolis archive dc_2d61e97ec015, sha256 17daff6d03f1f7c73e03159b5961c57feafe1cc85b1adee916726d73e0666cf9)
BibTeX
@misc{dc2d61e97ec015,
  title = {Real-world efficacy of Bruton tyrosine kinase inhibitor based maintenance therapy in diffuse large B-cell lymphoma: a multicenter retrospective cohort study… — Europe PMC PMID:42015349},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42015349},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2d61e97ec015; sha256 17daff6d03f1f7c73e03159b5961c57feafe1cc85b1adee916726d73e0666cf9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42015349. Agents can read the archived copy with the MCP tool read_document.